<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03296267</url>
  </required_header>
  <id_info>
    <org_study_id>s56880</org_study_id>
    <nct_id>NCT03296267</nct_id>
  </id_info>
  <brief_title>Influence of Bile Acids on Bacterial Uptake in Functional Dyspepsia</brief_title>
  <official_title>Translocation of Microorganisms in Duodenal Biopsies of Healthy Volunteers and Patients With Functional Dyspepsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In up to half of patients seen by gastroenterologists, routine examinations fail to find an&#xD;
      underlying organic, systemic, or metabolic disease that readily explains the symptoms. These&#xD;
      patients are referred to as patients with disorders of gastrointestinal function, of which&#xD;
      functional dyspepsia (FD) is one of the most common. Despite intensive research to&#xD;
      investigate various pathophysiological mechanisms of this disease, the pathogenesis remains&#xD;
      obscure. The investigators recently demonstrated increased duodenal permeability in FD&#xD;
      patients, as assessed by mounting routine endoscopic duodenal biopsy specimens into Ussing&#xD;
      chambers to measure transepithelial electrical resistance and passage of a paracellular&#xD;
      fluorescent probe. Impaired intestinal barrier function can lead to increased uptake of&#xD;
      luminal substances which can induce an immunological response in the mucosa. Interestingly,&#xD;
      using transmission electron microscopy (TEM) in duodenal biopsies, the investigators recently&#xD;
      observed the presence of a yet to be identified microorganism inside the epithelium and the&#xD;
      lamina propria of a subset of FD patients (unpublished observations), suggesting increased&#xD;
      translocation of microorganisms.&#xD;
&#xD;
      The aim of the project is to investigate whether FD patients display increased translocation&#xD;
      of microorganisms in duodenal biopsies. The investigators will also test the effect of bile&#xD;
      acid on translocation of microorganisms and therefore include 20 FD patients and 20 age- and&#xD;
      gender-matched healthy volunteers in this study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The participants will be expected on the department endoscopy of the University Hospital&#xD;
      Gasthuisberg, Leuven, Belgium. They are asked to fill in a bundle of questionnaires&#xD;
      concerning physical complaints, depression, anxiety (disturbances), pain/disease,&#xD;
      body/interoceptive awareness, trauma/abuse and personality. Endoscopy will be performed and&#xD;
      up to 8 biopsies will be obtained from the duodenum. All endoscopies will be performed by an&#xD;
      experienced endoscopist. Biopsies will be mounted in Ussing chambers and the mucosal&#xD;
      compartment will be exposed to commercially available fluorescein-conjugated microorganisms.&#xD;
      Uptake of microorganisms will be evaluated by analyzing the serosal compartment and by&#xD;
      confocal microscopy of the biopsies. These experiments will also be performed in combination&#xD;
      with exposure to bile acids separately and jointly, to assess if bacterial translocation can&#xD;
      be exacerbated by these endogenous luminal factors individually and synergistically.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 2, 2017</start_date>
  <completion_date type="Anticipated">April 20, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Bacterial uptake in the duodenal biopsy measured by fluorescent intensity at the basolateral side of the ussing chamber setup.</measure>
    <time_frame>120 minutes</time_frame>
    <description>duodenal uptake of fluorescein conjugated microorganisms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duodenal permeability assessed by measuring transepithelial electrical resistance in the Ussing chamber setup</measure>
    <time_frame>120 minutes</time_frame>
    <description>transepithelial electrical resistance</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Functional Dyspepsia</condition>
  <arm_group>
    <arm_group_label>gastroduodenoscopy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>all participants undergo a gastroduodenoscopy to use the biopsies in an Ussing chamber experiment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gastroduodenoscopy</intervention_name>
    <description>Gastroduodenoscopy with duodenal biospies: A tube is placed via the mouth into the second part of the duodenum. Biopsy forceps is used to take duodenal biopsies.</description>
    <arm_group_label>gastroduodenoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Three days before the measurement: no smoking and drinking alcohol&#xD;
&#xD;
          -  12 hours before the measurement: no drinking and eating&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  symptoms or history of gastrointestinal disease&#xD;
&#xD;
          -  first degree relatives with celiac disease&#xD;
&#xD;
          -  diabetes mellitus&#xD;
&#xD;
          -  allergy/atopy (eczema, asthma, allergic rhinoconjunctivitis)&#xD;
&#xD;
          -  coagulation disorders/anticoagulant therapy&#xD;
&#xD;
          -  first degree relatives with Crohn's disease or type I diabetes mellitus.&#xD;
&#xD;
          -  intake of antihistamines, ketotifen, cromoglycate, acetylsalicylates, NSAIDs,&#xD;
             anticholinergics, theophylline, Î²2-agonists, codeine or opioid derivatives for at&#xD;
             least 2 weeks prior to the gastroscopy&#xD;
&#xD;
          -  Intake of steroid or immunosuppressive drugs in the last 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Tack, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dorien Beeckmans, PhD</last_name>
    <phone>+3216 37 73 11</phone>
    <email>dorien.beeckmans@kuleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Translational Research center for Gastrointestinal Disorders (TARGID)</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorien Beeckmans</last_name>
      <phone>+3216 37 73 11</phone>
      <email>dorien.beeckmans@kuleuven.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>September 18, 2017</study_first_submitted>
  <study_first_submitted_qc>September 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2017</study_first_posted>
  <last_update_submitted>October 4, 2017</last_update_submitted>
  <last_update_submitted_qc>October 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bile acid</keyword>
  <keyword>bacterial uptake</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspepsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

